JP2017518275A5 - - Google Patents

Download PDF

Info

Publication number
JP2017518275A5
JP2017518275A5 JP2016565267A JP2016565267A JP2017518275A5 JP 2017518275 A5 JP2017518275 A5 JP 2017518275A5 JP 2016565267 A JP2016565267 A JP 2016565267A JP 2016565267 A JP2016565267 A JP 2016565267A JP 2017518275 A5 JP2017518275 A5 JP 2017518275A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
administered
aluminum
oxyhydroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016565267A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017518275A (ja
JP6692755B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/059339 external-priority patent/WO2015165966A1/en
Publication of JP2017518275A publication Critical patent/JP2017518275A/ja
Publication of JP2017518275A5 publication Critical patent/JP2017518275A5/ja
Application granted granted Critical
Publication of JP6692755B2 publication Critical patent/JP6692755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016565267A 2014-04-29 2015-04-29 アルツハイマー病(ad)の処置および予防 Active JP6692755B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14166354.2 2014-04-29
EP14166355.9 2014-04-29
EP14166355 2014-04-29
EP14166354 2014-04-29
PCT/EP2015/059339 WO2015165966A1 (en) 2014-04-29 2015-04-29 Treatment and prevention of alzheimer's disease (ad)

Publications (3)

Publication Number Publication Date
JP2017518275A JP2017518275A (ja) 2017-07-06
JP2017518275A5 true JP2017518275A5 (enExample) 2018-05-31
JP6692755B2 JP6692755B2 (ja) 2020-05-13

Family

ID=53039896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016565267A Active JP6692755B2 (ja) 2014-04-29 2015-04-29 アルツハイマー病(ad)の処置および予防

Country Status (18)

Country Link
US (1) US10478454B2 (enExample)
EP (2) EP3269376B1 (enExample)
JP (1) JP6692755B2 (enExample)
KR (1) KR102388363B1 (enExample)
CN (1) CN106659738B (enExample)
AU (1) AU2015254663B2 (enExample)
CA (1) CA2946928C (enExample)
CY (1) CY1119674T1 (enExample)
DK (1) DK3137093T3 (enExample)
ES (2) ES2824763T3 (enExample)
HR (1) HRP20171896T1 (enExample)
HU (1) HUE037501T2 (enExample)
LT (1) LT3137093T (enExample)
NO (1) NO3137093T3 (enExample)
PL (1) PL3137093T3 (enExample)
PT (1) PT3137093T (enExample)
SI (1) SI3137093T1 (enExample)
WO (1) WO2015165966A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106535924A (zh) 2014-04-29 2017-03-22 阿费里斯股份公司 阿尔茨海默病(ad)的治疗和预防
KR102506460B1 (ko) * 2014-04-29 2023-03-03 어드밴티지 테라퓨틱스, 인코포레이티드 알츠하이머병(ad)의 치료 및 예방

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016327A1 (en) * 1993-01-14 1994-07-21 Pollard Harvey B Methods and compositions for blocking amyloid protein ion channels
EP1007040B1 (en) * 1997-08-21 2002-05-08 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
CN104436212A (zh) * 2010-03-29 2015-03-25 诺华股份有限公司 包含与病毒样颗粒偶联的淀粉样β1-6肽及佐剂的组合物
CN106535924A (zh) * 2014-04-29 2017-03-22 阿费里斯股份公司 阿尔茨海默病(ad)的治疗和预防
KR102506460B1 (ko) * 2014-04-29 2023-03-03 어드밴티지 테라퓨틱스, 인코포레이티드 알츠하이머병(ad)의 치료 및 예방

Similar Documents

Publication Publication Date Title
JP2018138578A5 (enExample)
JP2015526467A5 (enExample)
AU2016204371A1 (en) Lyophilised and aqueous anti-CD40 antibody formulations
JP2011518119A5 (enExample)
JP2012051891A5 (enExample)
JP2020514412A5 (enExample)
JP2013513612A5 (enExample)
RU2016119746A (ru) Стабильный состав инсулина глулизин
JP2017533972A5 (enExample)
JP2016503058A5 (enExample)
EA201300314A8 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
JP2017518275A5 (enExample)
JP2019510757A (ja) ポリクオタニウムを含む抗菌性組成物
JP2019532095A5 (enExample)
JP2017514831A5 (enExample)
JP2017515812A5 (enExample)
KR20170124322A (ko) 알러지 질환 치료제 전달을 위한 용해성 미세바늘 패치
JP2020536098A5 (enExample)
JP2021502379A5 (enExample)
FI3137094T3 (fi) Alzheimerin taudin (ad) hoitaminen ja ehkäiseminen
SI3137093T1 (en) Treatment and prevention of Alzheimer's disease
JP2014502608A5 (enExample)
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina
JP2019507174A5 (enExample)
CN105726523A (zh) 一种用于治疗动物螨病的药物组合物及其制备方法和应用